Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Neuronetics, Inc. before investing.

In this article, we go over a few key elements for understanding Neuronetics, Inc.’s stock price such as:

• Neuronetics, Inc.’s current stock price and volume
• Why Neuronetics, Inc.’s stock price changed recently
• Upgrades and downgrades for STIM from analysts
• STIM’s stock price momentum as measured by its relative strength

About Neuronetics, Inc. (STIM)

Before we jump into Neuronetics, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Want to learn more about Neuronetics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Neuronetics, Inc..

Neuronetics, Inc.’s Stock Price as of Market Close

As of January 16, 2026, 4:00 PM, CST, Neuronetics, Inc.’s stock price was $1.900.

Neuronetics, Inc. is up 4.97% from its previous closing price of $1.810.

During the last market session, Neuronetics, Inc.’s stock traded between $1.800 and $1.970. Currently, there are approximately 67.31 million shares outstanding for Neuronetics, Inc..

Neuronetics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Neuronetics, Inc. Stock Price History

Neuronetics, Inc.’s (STIM) price is currently up 37.68% so far this month.

During the month of January, Neuronetics, Inc.’s stock price has reached a high of $2.130 and a low of $1.340.

Over the last year, Neuronetics, Inc. has hit prices as high as $5.920 and as low as $1.250. Year to date, Neuronetics, Inc.’s stock is up 37.68%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Neuronetics, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 16, 2026, there were 0 analysts who downgraded Neuronetics, Inc.’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Neuronetics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Neuronetics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Neuronetics, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Neuronetics, Inc. (STIM) by visiting AAII Stock Evaluator.

Relative Price Strength of Neuronetics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 16, 2026, Neuronetics, Inc. has a weighted four-quarter relative price strength of -5.36%, which translates to a Momentum Score of 32 and is considered to be Weak.

Want to learn more about how Neuronetics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Neuronetics, Inc. Stock Price: Bottom Line

As of January 16, 2026, Neuronetics, Inc.’s stock price is $1.900, which is up 4.97% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Neuronetics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.